METHOD OF DIFFERENTIATED PREDICTION OF RENAL DISEASES Russian patent published in 2002 - IPC

Abstract RU 2180965 C1

FIELD: medicine, nephrology. SUBSTANCE: the method deals with testing urinary proteins by automatically controlled electrophoresis in a gradient 8-25%-polyacrylamide gel with dodecyl sodium sulfate detergent. Moreover, protein fractions are studied within 10-330 kDa range. At combining protein fractions of 25-27 kDa mol. weight-α1-microglobulin, α1-acid glycoproteide and 58-75 kDa-prealbumin, albumin, postalbumin the standard is diagnosed. At determining protein fractions of 58-75 kDa mol. weight-prealbumin, albumin, postalbumin, 76-160 kDa-transferrin, monomer THP, haptoglobin, dimeric A1, immunoglobulans G and 161-330 kDa- immunoglobulins' fraction the glomerulopathies are diagnosed. At combining protein fractions of 10-24 kDa mol. weight - γ trace protein, β2-microglobulin, ribonuclease, lysozyme, monomeric hemoglobin, retinolbinding protein, 58-75 kDa - prealbumin, albumin, postalbumin, 76-160 kDa-transferrin, monomer THP, haptoglobin, dimeric A1, immunoglobulin G and 161-330 kDaimmunoglobulins' fraction - a combinative defects of glomerules and canaliculi are diagnosed, that is glomerulonephritis with tubulointerstitial component, at determining uroproteins of 10-24 kDa mol. weight - γ trace protein, β2-microglobulin, ribonuclease, lysozyme, monomeric hemoglobin, retinolbinding protein, 25-27 kDa-α1-microglobulin, α1-acid glycoproteide, 58-75 kDa-prealbumin, albumin, postalbumin, 76-160 kDa-transferrin, monomer THP, haptoglobulin, dimeric A1, immunoglobulin G the tubulointerstitial nephritis and tubulopathies are diagnosed. EFFECT: higher accuracy of differentiated diagnostics of renal diseases. 3 tbl

Similar patents RU2180965C1

Title Year Author Number
METHOD FOR DIAGNOSTICS OF DIABETIC NEPHROPATHY AT PRE-CLINICAL STAGE 2007
  • Gabbasova Natalija Vadimovna
  • Mamchik Nikolaj Petrovich
RU2348038C1
METHOD FOR MEASURING HUMAN MEGALINE 2007
  • Ogasavara Sinia
  • Miura Sukhen
  • Saito Akikhiko
  • Takeda Tetsuro
RU2463608C2
CELLULAR SYSTEM FOR TARGETED DELIVERY OF A PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL 2016
  • Krul, Magdalena
  • Benni, Iren
  • Bajokko, Paola
  • Rygel, Tomash
  • Boffi, Alberto
  • Shults, Aleksandra
  • Plikh, Sofiya
  • Tonetskaya, Katazhina
  • Ulevich, Katazhina
  • Tatsyak, Bartolomej
  • Kiraga, Lukash
RU2771323C2
FUSED DRUG CONSTRUCTS AND CONJUGATES 2005
  • Kholms Stiv
  • Khoult Ljusi Dzh.
  • Dzhespers Lorent S.
  • Tomlinson Ajan M.
RU2428431C2
RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND THEIR USE 2018
  • Berasi, Stephen
  • Buhlmann, Janet, Elizabeth
  • Higginson-Scott, Nathan
  • Shamashkin, Michael
  • Russo, Matthew
  • Gulla, Stefano, V.
  • Juo, Zong, Sean
  • Kodangattil, Sreekumar, R.
  • Lu, Weining
  • Fan, Xueping
  • Salant, David, J.
RU2791486C2
TREATING KIDNEY DISEASE IN SUBJECTS WITH RENAL AND/OR URINARY TRACT ABNORMALITIES 2020
  • Bertram, Timoti
  • Dzhain, Dipak
RU2823980C2
PHARMACEUTICAL COMPOSITION OF ANTI-CD20 ANTIBODY AND USE THEREOF 2022
  • Iakovlev Aleksandr Olegovich
  • Lomkova Ekaterina Aleksandrovna
  • Sozonova Aleksandra Aleksandrovna
  • Zinkina-Orikhan Arina Valerevna
  • Bolsun Daria Dmitrievna
  • Morozov Dmitrii Valentinovich
RU2824627C2
COMPOSITIONS CONTAINING CELL VESICLES AND USE THEREOF 2019
  • Bertram, Timothy
  • Jain, Deepak
RU2824136C2
IMMUNOLOGICALLY PRIVILEGED BIOACTIVE KIDNEY CELLS FOR TREATMENT OF KIDNEY DISEASE 2018
  • Bertram, Timothy, A.
  • Jain, Deepak
  • Basu, Joydeep
  • Ludlow, John, W.
RU2816753C2
ANTAGONISTS AND METHOD OF USING SAID ANTAGONISTS 2005
  • Brjuis Nil D.
  • Vulven Bendzhamin P.
  • Kholms Stiv
  • Tomlinson Ajan M.
  • Li Dzhennifer
  • Ehnever Karolin
  • Basran Amrik
  • Dzhouns Kejt
  • Vildt Ruud De
  • Blejn Stanislas Charlz
RU2401842C2

RU 2 180 965 C1

Authors

Gabbasova N.V.

Zhmaev A.F.

Nastausheva T.L.

Chernov Ju.N.

Stakhurlova L.I.

Shvyrev A.P.

Dates

2002-03-27Published

2000-07-03Filed